Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial
- PMID: 12925422
- PMCID: PMC180652
Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial
Erratum in
- CMAJ. 2004 Feb 17;170(4):451
Abstract
Background: There is growing evidence that better outcomes are achieved when anticoagulation is managed by anticoagulation clinics rather than by family physicians. We carried out a randomized controlled trial to evaluate these 2 models of anticoagulant care.
Methods: We randomly allocated patients who were expected to require warfarin sodium for 3 months either to anticoagulation clinics located in 3 Canadian tertiary hospitals or to their family physician practices. We evaluated the quality of oral anticoagulant management by comparing the proportion of time that the international normalized ratio (INR) of patients receiving warfarin sodium was within the target therapeutic range +/- 0.2 INR units (expanded therapeutic range) while they were managed in anticoagulation clinics as opposed to family physicians' care over 3 months. We measured the rates of thromboembolic and major hemorrhagic events and patient satisfaction in the 2 groups.
Results: Of the 221 patients enrolled, 112 were randomly assigned to anticoagulation clinics and 109 to family physicians. The INR values of patients who were managed by anticoagulation clinics were within the expanded therapeutic range 82% of the time versus 76% of the time for those managed by family physicians (p = 0.034). High-risk INR values (defined as being < 1.5 or > 5.0) were more commonly observed in patients managed by family physicians (40%) than in patients managed by anticoagulation clinics (30%, p = 0.005). More INR measurements were performed by family physicians than by anticoagulation clinics (13 v. 11, p = 0.001). Major bleeding events (2 [2%] v. 1 [1%]), thromboembolic events (1 [1%] v. 2 [2%]) and deaths (5 [4%] v. 6 [6%]) occurred at a similar frequency in the anticoagulation clinic and family physician groups respectively. Of the 170 (77%) patients who completed the patient satisfaction questionnaire, more were satisfied when their anticoagulant management was managed through anticoagulation clinics than by their family physicians (p = 0.001).
Interpretation: Anticoagulation clinics provided better oral anticoagulant management than family physicians, but the differences were relatively modest.
Figures
Comment in
-
Anticoagulation.CMAJ. 2004 Feb 17;170(4):447, 450; author reply 451. CMAJ. 2004. PMID: 14970077 Free PMC article. No abstract available.
-
Anticoagulation.CMAJ. 2004 Feb 17;170(4):447; author reply 451. CMAJ. 2004. PMID: 14970078 Free PMC article. No abstract available.
-
Anticoagulation.CMAJ. 2004 Feb 17;170(4):447; author reply 451. CMAJ. 2004. PMID: 14970079 Free PMC article. No abstract available.
-
Anticoagulation.CMAJ. 2004 Feb 17;170(4):450; author reply 451. CMAJ. 2004. PMID: 14970081 Free PMC article. No abstract available.
Similar articles
-
Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician.Pharmacotherapy. 2012 Feb;32(2):112-9. doi: 10.1002/PHAR.1011. Pharmacotherapy. 2012. PMID: 22392419 Clinical Trial.
-
Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.Br J Clin Pharmacol. 2006 Nov;62(5):601-9. doi: 10.1111/j.1365-2125.2006.02693.x. Br J Clin Pharmacol. 2006. PMID: 17061966 Free PMC article. Clinical Trial.
-
Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.Pharmacotherapy. 2008 Jan;28(1):20-6. doi: 10.1592/phco.28.1.20. Pharmacotherapy. 2008. PMID: 18154470
-
Frequency of adverse events in patients with poor anticoagulation: a meta-analysis.CMAJ. 2007 May 22;176(11):1589-94. doi: 10.1503/cmaj.061523. CMAJ. 2007. PMID: 17515585 Free PMC article. Review.
-
Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Nov. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Nov. PMID: 24278997 Free Books & Documents. Review.
Cited by
-
Applying the triple aim to the quality agenda for anticoagulation care.J Am Heart Assoc. 2013 Jul 29;2(4):e000377. doi: 10.1161/JAHA.113.000377. J Am Heart Assoc. 2013. PMID: 23896682 Free PMC article. No abstract available.
-
A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism.Afr Health Sci. 2009 Sep;9(3):179-85. Afr Health Sci. 2009. PMID: 20589148 Free PMC article. Clinical Trial.
-
Anticoagulation: where we are and where we need to go.J Thromb Thrombolysis. 2009 Aug;28(2):220-3. doi: 10.1007/s11239-008-0256-4. Epub 2008 Jul 18. J Thromb Thrombolysis. 2009. PMID: 18636228 Review.
-
Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study.PLoS One. 2023 Apr 18;18(4):e0284425. doi: 10.1371/journal.pone.0284425. eCollection 2023. PLoS One. 2023. PMID: 37071625 Free PMC article.
-
Medication therapy problems detected at community pharmacy INR checks.Can Pharm J (Ott). 2024 Dec 4;158(2):83-89. doi: 10.1177/17151635241291854. eCollection 2025 Mar-Apr. Can Pharm J (Ott). 2024. PMID: 39649478 Free PMC article.
References
-
- Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest 2001;119(Suppl 1): 132S-75S. - PubMed
-
- Hyers TM, Angelli G, Hull RD, Morris TA, Samama M, Tapson V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119 (Suppl 1):176S-93S. - PubMed
-
- Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE, et al. Antithrombotic therapy in atrial fibrillation. Chest 2001;19(Suppl 1):194S-206S. - PubMed
-
- Stein PD, Alpert JS, Bussy HI, Dalen JE, Turpie AGG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001;119(Suppl 1):220S-27S. - PubMed
-
- Cairns JA, Theroux P, Lewis HD, Ezekowitz M, Meade TW. Antithrombotic agents in coronary artery disease. Chest 2001;119(Suppl 1):228S-52S. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical